Boehringer Ingelheim Pharmaceuticals, Inc.

Kollol Pal

Julian Adams

John Robert Proudfoot

Karl D Hargrave

Karl G Grozinger

Ernest Cullen

Mark Behnke

Disclosed are novel pyrido[2,3,-b][1,5]benzodiazepines. These compounds are useful in the treatment of AIDS, ARC and related disorders associated with HIV infection. ##STR1##

Pyridobenzo- and pyridiothieno-diazepines useful for the treatment of

Disclosed are novel pyrido[2,3-b][1,4]benzodiazepines. These compounds are useful in the treatment of AIDS, ARC and related disorders associated with HIV infection. The compounds are of the class having the structure: ##STR1##

Pyridobenzo-and pyridiothieno-diazepines useful for the treatment of HIV

2-(1-pyrrolidino)-benzoxazoles of general formula ##STR1## are disclosed which are inhibitors of leukotriene biosynthesis.

Pyrrolidine derivatives inhibitors of leukotriene biosynthesis

Disclosed are novel dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the treatment of HIV-1 infection. An exemplary species is 6-chloro-11-cyclopropyl-4-methyl-11H-dipyrido[3,2-b:2',3'-e][1,4]diazepine , which has the following chemical structure: ##STR1##

Growing community of inventors

New Milford, CT, United States of America

Kollol Pal